pioglitazone has been researched along with Adjuvant Arthritis in 5 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The highest doses of rosiglitazone (10 mg/kg/day) or pioglitazone (30 mg/kg/day) were required to reduce fever peaks associated with acute or chronic inflammation, respectively, and to decrease arthritis severity." | 3.74 | Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. ( Bianchi, A; Jouzeau, JY; Koufany, M; Moulin, D; Muresan, M; Netter, P; Sebillaud, S; Weryha, G, 2008) |
| "Treatment with fenofibrate exerted a better effect on clinical scoring." | 1.40 | Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis. ( Jouzeau, JY; Koufany, M; Moulin, D, 2014) |
| "Adjuvant arthritis was induced by single intra-dermal injection of 0." | 1.39 | Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis. ( Banerjee, BD; Mediratta, PK; Negi, H; Sharma, KK; Suke, SG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, XF | 1 |
| Yin, SQ | 1 |
| Li, H | 1 |
| Yang, YL | 1 |
| Chen, X | 1 |
| Song, B | 1 |
| Wu, S | 1 |
| Wu, YY | 1 |
| Wang, H | 1 |
| Li, J | 1 |
| Koufany, M | 3 |
| Chappard, D | 1 |
| Netter, P | 2 |
| Bastien, C | 1 |
| Weryha, G | 2 |
| Jouzeau, JY | 3 |
| Moulin, D | 3 |
| Suke, SG | 1 |
| Negi, H | 1 |
| Mediratta, PK | 1 |
| Banerjee, BD | 1 |
| Sharma, KK | 1 |
| Bianchi, A | 1 |
| Muresan, M | 1 |
| Sebillaud, S | 1 |
5 other studies available for pioglitazone and Adjuvant Arthritis
| Article | Year |
|---|---|
PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Fibrob | 2023 |
The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
Topics: Animals; Arthritis, Experimental; Bone and Bones; Bone Density; Interleukin-17; Male; Osteoclasts; O | 2013 |
Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis.
Topics: Animals; Ankle; Anti-Inflammatory Agents; Arthritis, Experimental; Body Weight; Disease Progression; | 2013 |
Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Body Weight; Bone and Bones; Bone Densit | 2014 |
Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Biomarkers; | 2008 |